Comparison between the effectiveness of methadone & Acceptance & Commitment group combination therapy & methadone therapy in the prevention rate of relapse in people with opium abuse.

Study of the effectiveness of a combination of methadone treatment with group treatment based on Acceptance & Commitment therapy (ACT) versus methadone treatment in the prevention rate of relapse in people with abuse opioids.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016062328603N1

Enrollment

Registered

2017-03-02

Start date

2016-07-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental & behavioural disorders due to use of opioids. Mental and behavioural disorders due to use of opioids

Interventions

Intervention 1: Intervention groups: Combination therapy with Methadone therapy uses a protocol based on Acceptance & Commitment Therapy Acceptance & Commitment Hayes (2002). Sessions: 8 sessions of 9

Drug name: Methadone

Dose: 20 cc

Duration: 5 Months.

Prevention

Treatment - Drugs

Intervention groups: Combination therapy with Methadone therapy uses a protocol based on Acceptance & Commitment Therapy Acceptance & Commitment Hayes (2002). Sessions: 8 sessions of 90 minutes.

Control group: Methadone

Eligibility

Sex/Gender

Male

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Having informed consent to participate in research; Taking at least two weeks Methadone; Being male; Having a minimum of 18 & maximum of 45 years old. Exclusion criteria: Patient will be deleted after the two meeting absence; More severe problems, such as suicidal thoughts or have psychotic disorders

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Relapse prevention. Timepoint: Before the intervention, The intervention, Three months after the intervention. Method of measurement: Cravings questionnaire (DDQ), urine test kits.	—

Secondary

Measure	Time frame
Anxiety. Timepoint: Before the intervention; The intervention time; Three months after the intervention. Method of measurement: Beck Anxiety Inventory.;Depression. Timepoint: Before the intervention; The intervention time; Three months after the intervention. Method of measurement: Beck Depression Inventory.;Craving. Timepoint: Before the intervention; The intervention time; Three months after the intervention. Method of measurement: Craving Questionnaire (DDQ).;Quality of life. Timepoint: Before the intervention; The intervention time; Three months after the intervention. Method of measurement: Quality of Life Questionnaire (WHO).	—

Measure

Time frame

Anxiety. Timepoint: Before the intervention; The intervention time; Three months after the intervention. Method of measurement: Beck Anxiety Inventory.;Depression. Timepoint: Before the intervention; The intervention time; Three months after the intervention. Method of measurement: Beck Depression Inventory.;Craving. Timepoint: Before the intervention; The intervention time; Three months after the intervention. Method of measurement: Craving Questionnaire (DDQ).;Quality of life. Timepoint: Before the intervention; The intervention time; Three months after the intervention. Method of measurement: Quality of Life Questionnaire (WHO).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Dadashi

Zanjan University of Medical Sciences

Psy.mohsen@gmail.com+98 24 3370 3156

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026